FDA 483 - Silq Technologies Corporation - January 05, 2023

Silq Technologies Corporation, a Specification Developer, was inspected by the FDA, resulting in two observations. The inspection revealed deficiencies in the firm's quality system, specifically regarding the lack of regular management reviews and inadequately established procedures for handling complaints. These issues indicate a need for improved quality system oversight and complaint management processes.